Korean Biosimilars Giants Step Up Race To Become Innovators

Samsung Completes Bioepis Spin-Off

 
• By Jung Won Shin
  
evolution
Samsung, Celltrion Taking Different Strategies, Similar Therapeutic Focus (Shutterstock)

More from Strategy

More from Business